NWBONORTHWEST BIOTHERAPEUTICS INCvs its industry peers
A metric-by-metric comparison of NORTHWEST BIOTHERAPEUTICS INC against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NWBOEsta | — | — | — | — | -0.3%#1 | 28.2%#3 | -4347.9%#2 | — | -651.3%#2 | — | — | — |
| NRSNW | $2M#6 | — | — | — | — | -9.0%#6 | — | — | — | — | -93.1%#6 | — |
| NSRX | $31M#4 | — | 11.3x#2 | 0.0x#1 | — | -282.2%#8 | -0.4%#1 | -211.6%#4 | — | — | -56.9%#5 | — |
| NVS | $298.3B#1 | — | 6.5x#1 | — | — | 17.1%#4 | — | 30.3%#2 | — | — | 38.4%#1 | 2.6%#1 |
| NVSEF | — | — | — | — | — | 17.1%#4 | — | 30.3%#2 | — | — | — | — |
| OCEA | $5M#5 | — | — | — | — | 91.7%#2 | — | — | — | — | -46.8%#4 | — |
| OGI | $107M#2 | — | — | — | — | — | — | — | — | — | -30.4%#3 | — |
| ONCY | $98M#3 | — | — | — | — | -26.2%#7 | — | — | — | — | -10.5%#2 | — |
| OTLC | — | — | — | — | — | 5610.7%#1 | -4552.3%#3 | 94.7%#1 | -0.8%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-09.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice